-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2021 to 2023.
- Sutro Biopharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.3M, a 35.3% increase year-over-year.
- Sutro Biopharma, Inc. annual Operating Lease, Payments for 2023 was $8M, a 371% increase from 2022.
- Sutro Biopharma, Inc. annual Operating Lease, Payments for 2022 was $1.7M, a 72.6% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)